REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/03/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Claudia W. Stangle Leydig, Voit & Mayer, Ltd.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations being additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical products for biotechnological purposes, namely, chemicals for use in biotechnological research and product development; chemicals for use in the agrochemical industry
Classe 5
Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and for use in immunology and oncology; chemical preparations for pharmaceutical purposes for the treatment of cancer and for use in immunology and oncology; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for medical use in the nature of biological preparations for the treatment of cancer and for use immunology and oncology; medicines for human purposes, namely, medicines for the treatment of cancer and for use in immunology and oncology; adjuvants for medical purposes; biological tissue cultures for medical purposes; biological preparations being biological tissue cultures for veterinary purposes; biological preparations for medical purposes, namely, for treatment of cancer and for use in immunology and oncology; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; medical preparations, namely, for treatment of cancer and for use in oncology; diagnostic preparations and materials being diagnostic preparations for medical purposes; chemical preparations for medical purposes namely, for treatment of cancer and for use in immunology and oncology; immunomodulators being a type of pharmaceutical preparation for the treatment of cancer; immunostimulants; immunoassay reagents for medical use; chemotherapeutics; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes, namely, for the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances, namely, for treatment of cancer and for use in immunology and oncology; anti-cancer preparations
Classe 9
Downloadable computer software for use with medical diagnosis, research, and treatment, namely, for analyzing medical data and diagnosing medical conditions, for evaluation of suggested medical treatment, analyzing and evaluating medical data for mitigation or prevention of disease, for processing data related to clinical trials, and for use with the development, production, and research of pharmaceuticals, namely, data processing, data analysis and data evaluation, processing and analyzing data related to clinical trials, evaluating and analyzing pharmaceutical ingredients and facilitating formulation and administration of pharmaceuticals
Classe 42
Research and development services in the field of immunology; chemistry services, namely, research in the field of immunology and oncology; chemical laboratories; chemistry consultation; testing of chemicals; chemical analysis; scientific research relating to chemistry; chemical research laboratory services; research and development services in the field of chemistry; provision of scientific information relating to the chemical industry; preparation of reports relating to chemical research; research and development in the pharmaceutical and biotechnology fields; laboratory research services relating to pharmaceuticals; information technology consultancy services for the pharmaceutical and healthcare industries; scientific research; computer aided scientific research services; biochemical research and analysis; genetic research; clinical research in the field of immunology and oncology; biological research; biological analysis; scientific research relating to biology; custom development of biological samples for research purposes; medical research; research to develop new products; research in the field of gene therapy; research and development in the field of diagnostic preparations; information on the subject of scientific research in the field of biochemistry and biotechnology; consultancy relating to pharmaceutical research; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; conducting clinical trials for others for pharmaceutical products; research on the subject of pharmaceuticals; scientific laboratory services; scientific research services relating to the isolation and cultivation of human tissues and cells; computer aided scientific testing in the field of immunology and oncology; scientific and technological design, namely, design in the fields of biochemistry and biotechnology, namely, custom design of pharmaceuticals, chemicals, biological preparations, scientific software, pharmaceutical software, medical software, medical instruments and devices; software design and development; design and development of medical technology, namely, technology research in the field of medical instruments and devices; design and development of software for database management; pharmaceutical research and development; providing scientific information about the results of clinical trials for pharmaceutical products; technological research, namely, research in the field of pharmaceuticals; engineering services relating to computers, namely, computer-aided engineering services for the biotechnology industry; computer systems analysis
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/03/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
20/06/2021
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2021
FINAL DISPOSITION PROCESSED
02/06/2021
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/06/2021
REGISTERED-PRINCIPAL REGISTER
02/03/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/12/2020
PUBLISHED FOR OPPOSITION
15/12/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/11/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2020
EXAMINER'S AMENDMENT ENTERED
11/11/2020
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2020
EXAMINERS AMENDMENT E-MAILED
11/11/2020
EXAMINERS AMENDMENT -WRITTEN
11/11/2020
EXAMINER'S AMENDMENT ENTERED
21/10/2020
ASSIGNED TO LIE
20/10/2020
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/10/2020
EXAMINERS AMENDMENT E-MAILED
20/10/2020
EXAMINERS AMENDMENT -WRITTEN
20/10/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
08/10/2020
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2020
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2020
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2020
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2020
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2020
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2020
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2020
REFUSAL PROCESSED BY IB
24/04/2020
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/04/2020
REFUSAL PROCESSED BY MPU
08/04/2020
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/03/2020
NON-FINAL ACTION WRITTEN
19/03/2020
APPLICATION FILING RECEIPT MAILED
17/03/2020
ASSIGNED TO EXAMINER
13/03/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/03/2020
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/03/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.